Immunotherapy in Ovarian Cancer-Where Are We Going?

被引：0
|
作者：
Markman, Maurie [1 ,2 ]
机构：
[1] Canc Treatment Ctr Amer, Philadelphia, PA USA
[2] Drexel Univ, Coll Med, Philadelphia, PA 19104 USA
来源：
AMERICAN JOURNAL OF HEMATOLOGY-ONCOLOGY | 2016年 / 12卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Over the past decade there have been major advances in the use of several innovative immunotherapeutic strategies in the management of a number of malignancies. Unfortunately, to date, despite considerable efforts in ovarian cancer in this therapeutic domain there has been limited evidence of clinical utility. Provocative research in vaccine-based treatments and early signs of efficacy for checkpoint inhibitors hold the potential promise that this situation will change in the not-so-distant future.
引用
收藏
页码：13 / 15
页数：3
相关论文
共 50 条
  • [1] Prostate cancer immunotherapy: where are we and where are we going?
    De Velasco, Marco A.
    Uemura, Hirotsugu
    CURRENT OPINION IN UROLOGY, 2018, 28 (01) : 15 - 24
  • [2] Prevention of Ovarian Cancer: Where are We Now and Where are We Going?
    Rodriguez, Isabel V.
    Ghezelayagh, Talayeh
    Pennington, Kathryn P.
    Norquist, Barbara M.
    CURRENT ONCOLOGY REPORTS, 2024, 26 (11) : 1355 - 1366
  • [3] Immunotherapy for head and neck cancer: where are we now and where are we going?
    Bauml, Joshua M.
    Aggarwal, Charu
    Cohen, Roger B.
    ANNALS OF TRANSLATIONAL MEDICINE, 2019, 7
  • [4] Folic acid and cancer-where are we today?
    Miller, Joshua W.
    Ulrich, Cornelia M.
    LANCET, 2013, 381 (9871): : 974 - 976
  • [5] Immunotherapy options in metastatic renal cell cancer: where we are and where we are going
    Passalacqua, Rodolfo
    Buti, Sebastiano
    Tomasello, Gianluca
    Longarini, Raffaella
    Brighenti, Matteo
    Dalla Chiesa, Matteo
    EXPERT REVIEW OF ANTICANCER THERAPY, 2006, 6 (10) : 1459 - 1472
  • [6] Combining Radiotherapy with Immunotherapy in Cervical Cancer: Where Do We Stand and Where Are We Going?
    Peng, Yan
    Yan, Hongxiang
    Mei, Wuxuan
    Zhang, Pengfei
    Zeng, Changchun
    CURRENT TREATMENT OPTIONS IN ONCOLOGY, 2023, 24 (10) : 1378 - 1391
  • [7] Combining Radiotherapy with Immunotherapy in Cervical Cancer: Where Do We Stand and Where Are We Going?
    Yan Peng
    Hongxiang Yan
    Wuxuan Mei
    Pengfei Zhang
    Changchun Zeng
    Current Treatment Options in Oncology, 2023, 24 : 1378 - 1391
  • [8] Where are we going with sentinel nodes mapping in ovarian cancer?
    Kampan, Nirmala Chandralega
    Teik, Chew Kah
    Shafiee, Mohammed Nasir
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [9] PROTAC delivery in tumor immunotherapy: Where are we and where are we going?
    Li, Yiyang
    Wu, Yike
    Gao, Sihan
    Sun, Tao
    Jiang, Chen
    JOURNAL OF CONTROLLED RELEASE, 2025, 378 : 116 - 144
  • [10] Antibody-based immunotherapy for ovarian cancer: where are we at?
    Tse, B. W. C.
    Collins, A.
    Oehler, M. K.
    Zippelius, A.
    Heinzelmann-Schwarz, V. A.
    ANNALS OF ONCOLOGY, 2014, 25 (02) : 322 - 331
12345